Visualized Analysis of Advances and Hot Spots of Lianhua Qingwen in Recent 10 Years
10.13422/j.cnki.syfjx.20230318
- VernacularTitle:近10年连花清瘟研究现状与热点的可视化分析
- Author:
Kun LIAN
1
;
Xin LI
1
;
Duoting TAN
1
;
Bo NING
2
;
Zhixi HU
1
;
Lin LI
1
Author Information
1. Hunan University of Chinese Medicine，Changsha 410208，China
2. Shaanxi University of Chinese Medicine，Xianyang 712046，China
- Publication Type:Journal Article
- Keywords:
Lianhua Qingwen;
coronavirus disease-2019 （COVID-19）;
CiteSpace;
pharmacological effect;
clinical application
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2023;29(8):220-228
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo analyze relevant literature on Lianhua Qingwen preparations and clarify the research advances and hot spots in this field， so as to provide references for clinical rational application and further research. MethodLiterature related to Lianhua Qingwen preparations in the recent 10 years was retrieved from six databases， including China National Knowledge Infrastructure（CNKI）， VIP， Wanfang Data， PubMed， and Web of Science， followed by management and analysis by NoteExpress and CiteSpace. ResultFinally， 344 and 76 Chinese and English research articles were included， and the number of publications increased in recent years. The research articles were published in 162 Chinese and 48 English journals. Shijiazhuang Yiling Pharmaceutical Co.， Ltd. and Guangzhou Medical University were institutions with the largest number of Chinese and English publications， respectively. LIU Minyan was the author who had published the most articles. Keywords with high frequency included clinical efficacy， Lianhua Qingwen， inflammatory factors， traditional Chinese medicine， and coronavirus disease-2019（COVID-19）. Nineteen clusters， including clinical efficacy， Chinese medicine， Lianhua Qingwen， COVID-19， and influenza A virus， and 47 emergent keywords， including herpes zoster， pneumonia， inflammatory factors， influenza， and gut microbiota， were generated. ConclusionCooperation and exchanges in this field are insufficient. Research focuses on the clinical efficacy of Lianhua Qingwen in the treatment of COVID-19 and other diseases， pharmacological action and mechanism of antiviral drugs， and micro-mechanism research focuses on related pathways and target proteins， as well as the combination of Chinese and western medicines.
